Background: With a recent surge of clinical trials, the treatment of ischemic stroke has undergone dramatic changes.
Objective: To evaluate the impact of evidence and a revamped stroke protocol on a large healthcare system.
Methods: A retrospective review of 69 patients with ischemic stroke treated with intra-arterial therapy was carried out.